These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 2702665

  • 1. Interactions of the phenylpyrazolo steroid cortivazol with glucocorticoid receptors in steroid-sensitive and -resistant human leukemic cells.
    Thompson EB, Srivastava D, Johnson BH.
    Cancer Res; 1989 Apr 15; 49(8 Suppl):2253s-2258s. PubMed ID: 2702665
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comparison of two structurally diverse glucocorticoid receptor agonists: cortivazol selectively regulates a distinct set of genes separate from dexamethasone in CEM cells.
    Miller AL, Webb MS, Thompson EB.
    Steroids; 2007 Sep 15; 72(9-10):673-81. PubMed ID: 17606285
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Binding studies of RU486 in different Reuber hepatoma variants.
    Chasserot-Golaz S, Beck G.
    Receptor; 1993 Sep 15; 3(1):31-7. PubMed ID: 8348081
    [Abstract] [Full Text] [Related]

  • 10. Glucocorticoid versus antiglucocorticoid activity: can a single functional group modification of glucocorticoid steroids always convey antiglucocorticoid activity?
    Lamontagne N, Mercier L, Pons M, Thompson EB, Simons SS.
    Endocrinology; 1984 Jun 15; 114(6):2252-63. PubMed ID: 6547091
    [Abstract] [Full Text] [Related]

  • 11. Non-glucocorticoid receptor-mediated effects of the potent glucocorticoid deacylcortivazol.
    Harmon JM, Schmidt TJ, Thompson EB.
    Cancer Res; 1982 Jun 15; 42(6):2110-4. PubMed ID: 6951631
    [Abstract] [Full Text] [Related]

  • 12. The distinct agonistic properties of the phenylpyrazolosteroid cortivazol reveal interdomain communication within the glucocorticoid receptor.
    Yoshikawa N, Yamamoto K, Shimizu N, Yamada S, Morimoto C, Tanaka H.
    Mol Endocrinol; 2005 May 15; 19(5):1110-24. PubMed ID: 15677712
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cytotoxicity of cortivazol in childhood acute lymphoblastic leukemia.
    Styczynski J, Kurylak A, Wysocki M.
    Anticancer Res; 2005 May 15; 25(3B):2253-8. PubMed ID: 16158972
    [Abstract] [Full Text] [Related]

  • 16. High affinity binding and regulatory actions of dexamethasone-type I receptor complexes in mouse brain.
    Luttge WG, Davda MM, Rupp ME, Kang CG.
    Endocrinology; 1989 Sep 15; 125(3):1194-203. PubMed ID: 2759022
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Resistance of human leukemic CEM-C1 cells is overcome by synergism between glucocorticoid and protein kinase A pathways: correlation with c-Myc suppression.
    Medh RD, Saeed MF, Johnson BH, Thompson EB.
    Cancer Res; 1998 Aug 15; 58(16):3684-93. PubMed ID: 9721879
    [Abstract] [Full Text] [Related]

  • 19. Glucocorticoid-receptor-gene defects and resistance to glucocorticoid-induced apoptosis in human leukemic cell lines.
    Hala M, Hartmann BL, Böck G, Geley S, Kofler R.
    Int J Cancer; 1996 Nov 27; 68(5):663-8. PubMed ID: 8938150
    [Abstract] [Full Text] [Related]

  • 20. Identification of the activation-labile gene: a single point mutation in the human glucocorticoid receptor presents as two distinct receptor phenotypes.
    Ashraf J, Thompson EB.
    Mol Endocrinol; 1993 May 27; 7(5):631-42. PubMed ID: 8316249
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.